Your Source for Venture Capital and Private Equity Financings

AvantGuard Closes $2.85M Seed Round

NEW YORK, NY, AvantGuard, a fast-growing company in the antimicrobial industry, announced today the successful completion of its seed funding round, raising $2.85 million.
The funds will be used to accelerate the development and expansion of its innovative antimicrobial chemistries, as well as to hire additional scientists to further develop the product and expand the company's global reach.

The round included new investments from Blue Ledge Capital, as well as follow-on investments from SOSV, LaunchNY, and Red Bear Angels, a consortium of prominent investors with a proven track record.

AvantGuard is a chemistry-based technology and product company creating innovative solutions that provide long-term protection against viruses, bacteria, and fungi/mold, in a wide variety of applications. The company's unique proprietary combinations of specialty molecules and polymers are customized to provide prolonged antimicrobial efficacy to a wide range of surfaces and materials. AvantGuard's unique solutions can not only protect against pathogens for weeks or months, but also make surfaces easier to clean, resist adhesion, prevent fouling, and inhibit the formation of biofilms.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors